Partner news
News
Partner news
Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen
Read full storyPartner news
Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
Read full storyPartner news
Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer
Read full storyPartner news
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
Read full storyPartner news
Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools
Read full storyPartner news
Janssen to Acquire Investigational Bermekimab from XBiotech
Read full storyPartner news
Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.
Read full storyPartner news
Vifor Pharma enters into commercial collaboration in the US with Janssen
Read full storyPartner news
World-leading genomics project to give insights into health and disease - In a major advance for public health, a £200m project involving the government, charity and four leading pharmaceutical companies was announced today
Read full storyPartner news
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
Read full storyPartner news
Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.
Read full storyPartner news
Cala Health Raises $50 Million Series C Funding
Read full storyPartner news
TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform
Read full storyPartner news